CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY. International journal of medical sciences, [S. l.], v. 5, n. 05, p. 396–403, 2025. DOI: 10.55640/. Disponível em: https://www.academicpublishers.org/journals/index.php/ijms/article/view/4890.. Acesso em: 28 apr. 2026.